16.35 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
16.59
↗ 0.24 (1.49%)
POST MARKET (AS OF 06:29 PM EDT)
Post Market
AS OF 06:29 PM EDT
16.59
↗ 0.24 (1.49%)
Market: CLOSED
Open?$16.60
High?$17.01
Low?$16.02
Prev. Close?$16.35
Volume?1.3M
Avg. Volume?2.1M
VWAP?$16.44
Rel. Volume?0.63x
Bid / Ask
Bid?$15.50 × 100
Ask?$17.69 × 2.5K
Spread?$2.19
Midpoint?$16.60
Valuation & Ratios
Market Cap?859.4M
Shares Out?52.6M
Float?21.2M
Float %?86.6%
P/E Ratio?N/A
P/B Ratio?12.58
EPS?-$1.61
Dividend?0.00%
Ex-Dividend?N/A
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $16.36. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of May 22, 2026.
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
859.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?31
Piotroski F-Score?0/9Weak
Altman Z-Score?8.09Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?27.01%Squeeze Risk
Short Interest?5.7M
Days to Cover?8.1
Free Float21.2M
Avg Daily Volume708.2K
Settlement Date2026-04-30
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?2.15Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?12.58HIGH▾
Peers100
S&P15
P/S?14,566.90HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.6CHEAP▾
S&P97
EV/Sales?14,143.37HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-124.0%WEAK▾
S&P3
ROA?-84.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$834.5M
Fundamentals ratios updated end of day